royal osteoporosis society

5

royal osteoporosis society Company Information

Share ROYAL OSTEOPOROSIS SOCIETY
Live 
MatureSmallDeclining

Company Number

04995013

Registered Address

st james house the square, lower bristol road, bath, BA2 3BH

Industry

Other human health activities

 

Telephone

01761473251

Next Accounts Due

September 2024

Group Structure

View All

Directors

Neil Gittoes8 Years

Frances Grigg8 Years

View All

Shareholders

-0%

royal osteoporosis society Estimated Valuation

£1.9m

Pomanda estimates the enterprise value of ROYAL OSTEOPOROSIS SOCIETY at £1.9m based on a Turnover of £4.4m and 0.42x industry multiple (adjusted for size and gross margin).

royal osteoporosis society Estimated Valuation

£3.4m

Pomanda estimates the enterprise value of ROYAL OSTEOPOROSIS SOCIETY at £3.4m based on an EBITDA of £858.4k and a 3.9x industry multiple (adjusted for size and gross margin).

royal osteoporosis society Estimated Valuation

£12.3m

Pomanda estimates the enterprise value of ROYAL OSTEOPOROSIS SOCIETY at £12.3m based on Net Assets of £5.3m and 2.32x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Royal Osteoporosis Society Overview

Royal Osteoporosis Society is a live company located in bath, BA2 3BH with a Companies House number of 04995013. It operates in the other human health activities sector, SIC Code 86900. Founded in December 2003, it's largest shareholder is unknown. Royal Osteoporosis Society is a mature, small sized company, Pomanda has estimated its turnover at £4.4m with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Royal Osteoporosis Society Health Check

Pomanda's financial health check has awarded Royal Osteoporosis Society a 5 rating. We use a traffic light system to show it exceeds the industry average on 9 measures and has 2 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating5out of 5
positive_score

9 Strong

positive_score

1 Regular

positive_score

2 Weak

size

Size

annual sales of £4.4m, make it larger than the average company (£841.8k)

£4.4m - Royal Osteoporosis Society

£841.8k - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 0%, show it is growing at a slower rate (4.7%)

0% - Royal Osteoporosis Society

4.7% - Industry AVG

production

Production

with a gross margin of 34.7%, this company has a comparable cost of product (34.7%)

34.7% - Royal Osteoporosis Society

34.7% - Industry AVG

profitability

Profitability

an operating margin of 15.8% make it more profitable than the average company (7.3%)

15.8% - Royal Osteoporosis Society

7.3% - Industry AVG

employees

Employees

with 49 employees, this is above the industry average (20)

49 - Royal Osteoporosis Society

20 - Industry AVG

paystructure

Pay Structure

on an average salary of £51.4k, the company has a higher pay structure (£24.6k)

£51.4k - Royal Osteoporosis Society

£24.6k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £90k, this is more efficient (£48k)

£90k - Royal Osteoporosis Society

£48k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 3 days, this is earlier than average (24 days)

3 days - Royal Osteoporosis Society

24 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 20 days, this is slower than average (16 days)

20 days - Royal Osteoporosis Society

16 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 0 days, this is less than average (9 days)

0 days - Royal Osteoporosis Society

9 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 207 weeks, this is more cash available to meet short term requirements (109 weeks)

207 weeks - Royal Osteoporosis Society

109 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 16%, this is a lower level of debt than the average (26.1%)

16% - Royal Osteoporosis Society

26.1% - Industry AVG

ROYAL OSTEOPOROSIS SOCIETY financials

EXPORTms excel logo

Royal Osteoporosis Society's latest turnover from December 2022 is £4.4 million and the company has net assets of £5.3 million. According to their latest financial statements, Royal Osteoporosis Society has 49 employees and maintains cash reserves of £3.2 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover4,409,5074,288,8825,075,6684,454,3244,566,0174,367,9064,841,2094,801,4564,921,6343,369,4713,469,4163,237,1823,528,6914,227,808
Other Income Or Grants00000000000000
Cost Of Sales2,877,8472,911,7533,438,1782,990,4333,091,7582,873,0323,127,5913,134,9973,224,1702,213,6222,137,1471,952,1072,107,0100
Gross Profit1,531,6601,377,1291,637,4901,463,8911,474,2591,494,8741,713,6181,666,4591,697,4641,155,8491,332,2691,285,0751,421,6810
Admin Expenses835,197733,281-1,6602,027,5082,748,3721,985,5961,948,187712,835596,7281,159,0681,326,7271,466,1173,384,5441,675,605
Operating Profit696,463643,8481,639,150-563,617-1,274,113-490,722-234,569953,6241,100,736-3,2195,542-181,042-1,962,863-1,675,605
Interest Payable000000041,313038,70237,75832,03729,54015,456
Interest Receivable00000000000000
Pre-Tax Profit630,020524,3101,328,417-558,919-1,268,791-484,445-230,102770,882875,7172,68511,767-172,593-1,955,803-1,671,700
Tax00000000000000
Profit After Tax630,020524,3101,328,417-558,919-1,268,791-484,445-230,102770,882875,7172,68511,767-172,593-1,955,803-1,671,700
Dividends Paid000000052,788000000
Retained Profit630,020524,3101,328,417-558,919-1,268,791-484,445-230,102718,094875,7172,68511,767-172,593-1,955,803-1,671,700
Employee Costs2,516,2412,132,8312,640,5533,373,3173,388,4503,105,6492,865,1102,405,0082,047,0301,927,5611,856,2561,943,3591,985,4642,113,856
Number Of Employees4938486570676257504949545657
EBITDA*858,362965,0661,775,743-508,365-1,209,742-429,829-234,5691,017,8051,152,27756,84176,870-78,765-1,859,082-1,578,039

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets227,4331,613,1741,669,5631,725,6341,777,4531,828,2451,873,7991,925,0861,984,9651,984,0282,043,2682,114,5962,189,6222,287,900
Intangible Assets27,159135,793244,427249,4790000000000
Investments & Other2,551,2812,771,3701,981,6641,454,8972,371,3073,496,3722,876,6152,557,1022,565,1992,514,4281,855,9581,485,7991,567,0171,106,658
Debtors (Due After 1 year)00000000000000
Total Fixed Assets2,805,8734,520,3373,895,6543,430,0104,148,7605,324,6174,750,4144,482,1884,550,1644,498,4563,899,2263,600,3953,756,6393,394,558
Stock & work in progress1,0871,2462,3953,3464,0560016,944000000
Trade Debtors38,11430,347472,043120,15872,14013,102116,84244,791240,990470,81548,18815,58240,89034,062
Group Debtors00000000000000
Misc Debtors285,178327,4670969,590682,303833,502588,5291,277,4520158,54078,110109,610133,33381,499
Cash3,153,1901,494,7971,263,483478,646774,133645,0961,865,8371,708,1152,283,355823,3891,859,0472,117,3421,262,1641,561,923
misc current assets000009,54316,606000001,575,1552,622,693
total current assets3,477,5691,853,8571,737,9211,571,7401,532,6321,501,2432,587,8143,047,3022,524,3451,452,7441,985,3452,242,5343,011,5424,300,177
total assets6,283,4426,374,1945,633,5755,001,7505,681,3926,825,8607,338,2287,529,4907,074,5095,951,2005,884,5715,842,9296,768,1817,694,735
Bank overdraft00000000000000
Bank loan00000000000000
Trade Creditors 158,046102,960515,349185,474274,446145,996173,063113,002191,203112,27764,84780,234198,348259,454
Group/Directors Accounts00000000000000
other short term finances00000000000000
hp & lease commitments00000000000000
other current liabilities633,429455,6650444,302476,053302,699419,492686,665939,813839,0911,005,3701,095,9601,663,059683,353
total current liabilities791,475558,625515,349629,776750,499448,695592,555799,6671,131,016951,3681,070,2171,176,1941,861,407942,807
loans00000000000000
hp & lease commitments00000000000000
Accruals and Deferred Income00000000000000
other liabilities213,005187,00313,97000000000000
provisions00000000000000
total long term liabilities213,005187,00313,97000000000000
total liabilities1,004,480745,628529,319629,776750,499448,695592,555799,6671,131,016951,3681,070,2171,176,1941,861,407942,807
net assets5,278,9625,628,5665,104,2564,371,9744,930,8936,377,1656,745,6736,729,8235,943,4934,999,8324,814,3544,666,7354,906,7746,751,928
total shareholders funds5,278,9625,628,5665,104,2564,371,9744,930,8936,377,1656,745,6736,729,8235,943,4934,999,8324,814,3544,666,7354,906,7746,751,928
Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit696,463643,8481,639,150-563,617-1,274,113-490,722-234,569953,6241,100,736-3,2195,542-181,042-1,962,863-1,675,605
Depreciation53,265160,60955,11755,25264,37160,893064,18151,54160,06071,328102,277103,78197,566
Amortisation108,634160,60981,47600000000000
Tax00000000000000
Stock-159-1,149-951-7104,0560-16,94416,944000000
Debtors-34,522-114,229-617,705335,305-92,161141,233-616,8721,081,253-388,365503,0571,106-49,03158,662115,561
Creditors55,086-412,389329,875-88,972128,450-27,06760,061-78,20178,92647,430-15,387-118,114-61,106259,454
Accruals and Deferred Income177,764455,665-444,302-31,751173,354-116,793-267,173-253,148100,722-166,279-90,590-567,099979,706683,353
Deferred Taxes & Provisions00000000000000
Cash flow from operations1,125,8931,123,7202,279,972-963,683-819,833-714,922192,135-411,7411,720,290-565,065-30,213-714,947-999,144-750,793
Investing Activities
capital expenditure0000934,006-519,159-82,99419,243-35,305-476,497-234,307-13,479-355,213-991,943
Change in Investments-220,089789,706526,767-916,410-1,125,065619,757319,513-8,09750,771658,470370,159-81,218460,3591,106,658
cash flow from investments220,089-789,706-526,767916,4102,059,071-1,138,916-402,50727,340-86,076-1,134,967-604,46667,739-815,572-2,098,601
Financing Activities
Bank loans00000000000000
Group/Directors Accounts00000000000000
Other Short Term Loans 00000000000000
Long term loans00000000000000
Hire Purchase and Lease Commitments00000000000000
other long term liabilities26,002173,03313,97000000000000
share issue-979,6240-596,1350-177,481115,937245,95268,23667,944182,793135,852-67,446110,6498,423,628
interest0000000-41,3130-38,702-37,758-32,037-29,540-15,456
cash flow from financing-953,622173,033-582,1650-177,481115,937245,95226,92367,944144,09198,094-99,48381,1098,408,172
cash and cash equivalents
cash1,658,393231,314784,837-295,487129,037-1,220,741157,722-575,2401,459,966-1,035,658-258,295855,178-299,7591,561,923
overdraft00000000000000
change in cash1,658,393231,314784,837-295,487129,037-1,220,741157,722-575,2401,459,966-1,035,658-258,295855,178-299,7591,561,923

royal osteoporosis society Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for royal osteoporosis society. Get real-time insights into royal osteoporosis society's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Royal Osteoporosis Society Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for royal osteoporosis society by selecting its closest rivals and benchmarking them against 12 key performance metrics.

royal osteoporosis society Ownership

ROYAL OSTEOPOROSIS SOCIETY group structure

Royal Osteoporosis Society has 1 subsidiary company.

Ultimate parent company

ROYAL OSTEOPOROSIS SOCIETY

04995013

1 subsidiary

ROYAL OSTEOPOROSIS SOCIETY Shareholders

--

royal osteoporosis society directors

Royal Osteoporosis Society currently has 14 directors. The longest serving directors include Dr Neil Gittoes (Jul 2015) and Mrs Frances Grigg (Jul 2015).

officercountryagestartendrole
Dr Neil Gittoes58 years Jul 2015- Director
Mrs Frances GriggEngland65 years Jul 2015- Director
Mr Richard DarchEngland62 years Feb 2019- Director
Dr Rosemary LeonardEngland67 years May 2019- Director
Dr Nicola PeelEngland63 years May 2019- Director
Mr Peter GothamEngland72 years Jul 2019- Director
Ms Judith Lyons59 years Jun 2022- Director
Mr Paul HerbertEngland53 years Jun 2022- Director
Mrs Teresa HicksEngland43 years Sep 2022- Director
Mr Ian Cooper63 years Sep 2022- Director

P&L

December 2022

turnover

4.4m

+3%

operating profit

696.5k

0%

gross margin

34.8%

+8.18%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2022

net assets

5.3m

-0.06%

total assets

6.3m

-0.01%

cash

3.2m

+1.11%

net assets

Total assets minus all liabilities

royal osteoporosis society company details

company number

04995013

Type

Private Limited by guarantee without Share Capital Exempt from using Limited

industry

86900 - Other human health activities

incorporation date

December 2003

age

21

accounts

Group

ultimate parent company

None

previous names

national osteoporosis society (January 2019)

incorporated

UK

address

st james house the square, lower bristol road, bath, BA2 3BH

last accounts submitted

December 2022

royal osteoporosis society Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to royal osteoporosis society.

charges

royal osteoporosis society Companies House Filings - See Documents

datedescriptionview/download